Cancer Discovery Scores High in New Journal Rankings Report
PHILADELPHIA — Cancer Discovery, a journal of the American Association for Cancer Research (AACR), ranked ninth of 196 oncology-focused, peer-reviewed journals in terms of impact factor, according to the latest Journal Citation Report from Thomson-Reuters, the industry standard for journal impact measurement.
In its first year to receive an impact factor, Cancer Discovery was given 10.143.
Cancer Discovery is co-led by editors-in-chief Lewis C. Cantley, Ph.D., director of the cancer center at Weill Cornell Medical College and New York-Presbyterian Hospital, and José Baselga, M.D., Ph.D., physician-in-chief at Memorial Sloan-Kettering Cancer Center.
“The AACR launched Cancer Discovery in 2011 to provide a publication outlet that would capture the most significant work across the breadth of the cancer research field,” said Margaret Foti, Ph.D., M.D. (h.c.), chief executive officer of the AACR. “The results of this report show that we achieved our goal. To have done this in less than two years is a tribute to the hard work and commitment of Drs. Cantley and Baselga and our dedicated scientific editors, all of whom have given so generously of their time and wisdom.”
Unique among other journals in the oncology category, Cancer Discovery publishes high-impact, peer-reviewed articles describing major advances in basic, translational, and clinical research, as well as cancer science news, review articles, perspectives, commentaries, and summaries of other important peer-reviewed journal articles.
Cancer Discovery is one of eight journals published by the AACR. The others are Cancer Research; Clinical Cancer Research; Cancer Epidemiology, Biomarkers & Prevention; Molecular Cancer Research; Molecular Cancer Therapeutics; Cancer Prevention Research; and Cancer Immunology Research.
About the American Association for Cancer Research
Founded in 1907, the American Association for Cancer Research (AACR) is the world’s oldest and largest professional organization dedicated to advancing cancer research and its mission to prevent and cure cancer. AACR membership includes more than 34,000 laboratory, translational, and clinical researchers; population scientists; other health care professionals; and cancer advocates residing in more than 90 countries. The AACR marshals the full spectrum of expertise of the cancer community to accelerate progress in the prevention, biology, diagnosis, and treatment of cancer by annually convening more than 20 conferences and educational workshops, the largest of which is the AACR Annual Meeting with more than 18,000 attendees. In addition, the AACR publishes eight peer-reviewed scientific journals and a magazine for cancer survivors, patients, and their caregivers. The AACR funds meritorious research directly as well as in cooperation with numerous cancer organizations. As the scientific partner of Stand Up To Cancer, the AACR provides expert peer review, grants administration, and scientific oversight of team science and individual grants in cancer research that have the potential for near-term patient benefit. The AACR actively communicates with legislators and policymakers about the value of cancer research and related biomedical science in saving lives from cancer. For more information about the AACR, visit www.AACR.org.